The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 3 randomized study of ASP-1929 photoimmunotherapy in combination with pembrolizumab versus standard of care in locoregional recurrent head and neck squamous cell carcinoma (HNSCC).
 
Ann Gillenwater
Consulting or Advisory Role - Rakuten Medical
 
David Cognetti
Consulting or Advisory Role - Rakuten Medical
 
Matthew Mifsud
No Relationships to Disclose
 
Noman Ashraf
Consulting or Advisory Role - Bristol Myers Squibb
 
Francisco Civantos
No Relationships to Disclose
 
Hassan Danesi
Employment - Rakuten Medical
Leadership - Rakuten Medical
Stock and Other Ownership Interests - Rakuten Medical
Travel, Accommodations, Expenses - Rakuten Medical
 
Bogdan Veresh
Employment - Rakuten Medical
 
Shiou-Yi Ethan Chen
Employment - Rakuten Medical
Stock and Other Ownership Interests - Rakuten Medical
Travel, Accommodations, Expenses - Rakuten Medical
 
Haiying Dong
No Relationships to Disclose
 
Cristina Larracas
Employment - Rakuten Medical
Stock and Other Ownership Interests - Abbott Laboratories; Rakuten Medical
Travel, Accommodations, Expenses - Rakuten Medical
 
Susanne Arnold
Consulting or Advisory Role - Penn State Cancer Institute
Research Funding - AstraZeneca (Inst); BeiGene (Inst); Bicara Therapeutics, Inc (Inst); Ellipses Pharma (Inst); Fortrea Inc (Inst); Genmab (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Kinnate Biopharma (Inst); Lilly (Inst); Lisata Therapeutics, Inc. (Inst); Merck Sharp & Dohme (Inst); Mirati Therapeutics (Inst); National Cancer Institute (Inst); Ohio State University (Inst)